Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Trends and Finance
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
The platform is used to gather and analyze physiological data for clinical trials evaluating new therapeutics. Empatica is collaborating with researchers on digital biomarkers for use as endpoints.
November 23, 2022
Meridian Bioscience Q4 revenues drop 14% on lower COVID-19 testing, misses analysts' estimates
Diagnostics segment revenue growth was driven by nonmolecular assay products, which increased 22%.
November 22, 2022
Castle Biosciences Pittsburgh laboratory receives CAP accreditation
All of Castle Biosciences' laboratories are now accredited by the College of American Pathologists.
November 21, 2022
Agilent Technologies Q4 revenues rise 11%
The Diagnostics and Genomics Group generated fourth-quarter revenue of $352 million, up 3% year-over-year.
November 21, 2022
Juno Diagnostics launches noninvasive prenatal screening test
The Juno Hazel test leverages a sample collection kit to enable the immediate generation of blood plasma for testing using a few drops of blood.
November 18, 2022
Twist Bioscience Q4 revenues rise 51%
Among its recent business highlights, the firm noted that it collaborated with PacBio to develop an initial portfolio of off-the-shelf long-read gene panels, including a 50-gene pharmacogenomics panel.
November 18, 2022
Most Popular
DNA forensic evidence frees Ohio man of rape, attempted rape
Low-value prostate cancer screening has Medicare spending ramifications, study finds
‘Good’ cholesterol worse for some adults: NIH study
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
PerkinElmer launches adeno-associated virus vector detection kits for research
Widespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. study
Pictor, Rako Science, Tasso providing COVID-19 antibody testing in New Zealand
The assay, using a remote collection device from Tasso, detects whether the patient has spike protein and nucleocapsid protein antibodies or spike protein antibodies alone, which would indicate vaccination.
November 17, 2022
Blood volume diagnostic firm Daxor closes $2.1M offering of common stock
The New York firm plans to use the net proceeds to develop its products, fund capital expenditures, or invest in or acquire other businesses, among other potential uses.
November 17, 2022
Physician, medical office to pay more than $2.6M involving clinical lab kickbacks
Feel Well Health and its owner violated the Anti-Kickback Statute by receiving remuneration from Boston Heart Diagnostics for clinical laboratory services for Medicare patients, according to the DOJ.
November 15, 2022
Biodesix secures loan of up to $50M, announces $35.1M stock offering
The developer of diagnostic tests that combine multiomics through AI said it will use the loan to strengthen its balance sheet, reduce near-term cash use, and enable the continued growth trajectory of its core lung diagnostics business.
November 17, 2022
DermTech, Sonora Quest ink deal to broaden access to melanoma detection test
Under the agreement, Sonora Quest becomes the exclusive laboratory provider in Arizona for DermTech’s melanoma test.
November 16, 2022
AMP 2022 video: Immunexpress CEO describes rapid molecular test for sepsis
At the Association for Molecular Pathology 2022 annual meeting and exposition recently, Immunexpress showcased a rapid molecular diagnostic test that could enable ruling in or ruling out sepsis in one hour.
November 15, 2022
Page 1 of 105
Next Page
